These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33818992)

  • 1. Hidradenitis suppurativa patient perspectives during the COVID-19 pandemic.
    Price KN; Collier EK; Grogan TR; Hsiao JL; Shi VY
    Dermatol Online J; 2021 Feb; 27(2):. PubMed ID: 33818992
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on patients with hidradenitis suppurativa.
    Fiocco Z; Schlager JG; Kendziora B; Patzak L; Kupf S; French LE; Hartmann D
    Int Wound J; 2022 Nov; 19(7):1686-1692. PubMed ID: 35128802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis Suppurativa Reddit Support Group: Finding New Meaning in Social Media During the COVID-19 Pandemic.
    Yesantharao LV; Suresh R; Lerman SF; Cox C; Caffrey J
    J Burn Care Res; 2023 Mar; 44(2):373-380. PubMed ID: 36521015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Support group utilization and impact for patients with hidradenitis suppurativa.
    Butt M; Cotton C; Kirby JS
    J Am Acad Dermatol; 2020 Jul; 83(1):216-219. PubMed ID: 31541749
    [No Abstract]   [Full Text] [Related]  

  • 5. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2.
    Vekic DA; Cains GD
    Australas J Dermatol; 2018 Nov; 59(4):261-266. PubMed ID: 29363099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in Hidradenitis Suppurativa-Patient Perspectives and Practice Gaps.
    Adelekun AA; Villa NM; Hsiao JL; Micheletti RG
    JAMA Dermatol; 2021 Feb; 157(2):227-230. PubMed ID: 33439230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Pearls for Managing Hidradenitis Suppurativa Patients of Low Socioeconomic Status.
    McKenzie SA; Lev-Tov HA; Shi VY; Hsiao JL
    Dermatology; 2020; 236(5):439-444. PubMed ID: 31927547
    [No Abstract]   [Full Text] [Related]  

  • 8. Hidradenitis suppurativa: A growing concern.
    Jemec GB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S3. PubMed ID: 26470612
    [No Abstract]   [Full Text] [Related]  

  • 9. Telemedicine: an imperative concept during COVID-19 pandemic in Africa.
    David KB; Solomon JK; Yunusa I; Lawal BK; Marshal CS; Okereke M; Ozuluoha CC
    Pan Afr Med J; 2020; 35(Suppl 2):129. PubMed ID: 33282084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living with hidradenitis suppurativa.
    Solarski ST
    Dermatol Nurs; 2004 Oct; 16(5):447-9. PubMed ID: 15624710
    [No Abstract]   [Full Text] [Related]  

  • 11. Hidradenitis Suppurativa: A Novel Model of Care and an Integrative Strategy to Adopt an Orphan Disease.
    Gulliver W; Landells IDR; Morgan D; Pirzada S
    J Cutan Med Surg; 2018; 22(1):71-77. PubMed ID: 29056071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa through the lens of YouTube: A cross-sectional analysis.
    Li W; Ma JE; Chan AA; Lee DJ; Smogorzewski J
    J Am Acad Dermatol; 2021 May; 84(5):1398-1399. PubMed ID: 32522514
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral Health in America During the COVID-19 Pandemic: Meeting Increased Needs Through Access to High Quality Virtual Care.
    Mochari-Greenberger H; Pande RL
    Am J Health Promot; 2021 Feb; 35(2):312-317. PubMed ID: 33554622
    [No Abstract]   [Full Text] [Related]  

  • 14. Hidradenitis suppurativa: racial and socioeconomic considerations in management.
    Choi ECE; Phan PHC; Oon HH
    Int J Dermatol; 2022 Dec; 61(12):1452-1457. PubMed ID: 35333408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial impact of hidradenitis suppurativa: a qualitative study.
    Esmann S; Jemec GB
    Acta Derm Venereol; 2011 May; 91(3):328-32. PubMed ID: 21394419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body Image Quality of Life in Patients with Hidradenitis Suppurativa Compared with Other Dermatological Disorders.
    Andersen PL; Nielsen RM; Sigsgaard V; Jemec GBE; Riis PT
    Acta Derm Venereol; 2020 Apr; 100(8):adv00107. PubMed ID: 32201901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event.
    Shukla N; Paul M; Halley M; Lowes MA; Hester V; Aguilar C; Guilbault S; Long TS; Taylor A; Thompson AC; Yannuzzi CA; Linos E; Naik HB
    Br J Dermatol; 2020 Jun; 182(6):1490-1492. PubMed ID: 31883104
    [No Abstract]   [Full Text] [Related]  

  • 18. Hidradenitis Suppurativa: A Case Study.
    Schulman ML; Pantuso HM
    J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
    [No Abstract]   [Full Text] [Related]  

  • 19. Hidradenitis Suppurativa: The Disease Which Stimulates Researchers and Clinicians.
    Szepietowski JC; Matusiak Ł
    Dermatology; 2020; 236(1):5-7. PubMed ID: 31955165
    [No Abstract]   [Full Text] [Related]  

  • 20. The psychosocial impact of hidradenitis suppurativa.
    Gooderham M; Papp K
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S19-22. PubMed ID: 26470609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.